Liu Z - Search Results

1

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma.

Zhang Y, Liu Z, Ji K, Li X, Wang C, Ren Z, Liu Y, Chen X, Han X, Meng L, Li L, Li Z. Zhang Y, et al. Among authors: liu z, liu y. Front Mol Biosci. 2021 Sep 29;8:736330. doi: 10.3389/fmolb.2021.736330. eCollection 2021. Front Mol Biosci. 2021. PMID: 34660697 Free PMC article. Review.

2

[Investigation and analysis of protein and energy intake in adult patients with severe burns].

Li JQ, Han X, Zhang MJ, Li XB, Liu GJ, Zhang JQ, Liu ZJ. Li JQ, et al. Among authors: liu zj, liu gj. Zhonghua Shao Shang Za Zhi. 2019 Feb 20;35(2):143-147. doi: 10.3760/cma.j.issn.1009-2587.2019.02.010. Zhonghua Shao Shang Za Zhi. 2019. PMID: 30798581 Chinese.

3

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma.

Liu Z, Zhang Y, Shi C, Zhou X, Xu K, Jiao D, Sun Z, Han X. Liu Z, et al. J Transl Med. 2021 Jan 6;19(1):5. doi: 10.1186/s12967-020-02697-y. J Transl Med. 2021. PMID: 33407585 Free PMC article.

4

Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and In Vitro Experiments.

Yao Y, Jiao D, Liu Z, Chen J, Zhou X, Li Z, Li J, Han X. Yao Y, et al. Among authors: liu z. Biomed Res Int. 2020 Dec 9;2020:5976127. doi: 10.1155/2020/5976127. eCollection 2020. Biomed Res Int. 2020. PMID: 33490245 Free PMC article.

5

Roles of Bile-Derived Exosomes in Hepatobiliary Disease.

Yao Y, Jiao D, Li Z, Zhou X, Li J, Liu Z, Han X. Yao Y, et al. Among authors: liu z. Biomed Res Int. 2021 Jan 13;2021:8743409. doi: 10.1155/2021/8743409. eCollection 2021. Biomed Res Int. 2021. PMID: 33511212 Free PMC article. Review.

6

Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management.

Liu Z, Liu L, Lu T, Wang L, Li Z, Jiao D, Han X. Liu Z, et al. Among authors: liu l. J Oncol. 2021 Jan 20;2021:6664386. doi: 10.1155/2021/6664386. eCollection 2021. J Oncol. 2021. PMID: 33552157 Free PMC article.

7

TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer.

Liu Z, Wang L, Guo C, Liu L, Jiao D, Sun Z, Wu K, Zhao Y, Han X. Liu Z, et al. Among authors: liu l. J Cell Mol Med. 2021 Apr;25(7):3239-3251. doi: 10.1111/jcmm.16393. Epub 2021 Feb 23. J Cell Mol Med. 2021. PMID: 33624434 Free PMC article.

8

Making timely remedial measures after TACE based on the results of cone-beam CT liver perfusion.

Li Z, Jiao D, Si G, Han X, Zhang W, Li Y, Zhou X, Liu J, Li J, Liu Z. Li Z, et al. Among authors: liu j, liu z. Int J Hyperthermia. 2021;38(1):428-436. doi: 10.1080/02656736.2021.1895331. Int J Hyperthermia. 2021. PMID: 33691589 Free article.

9

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.

Liu Z, Jiao D, Liu L, Zhou X, Yao Y, Li Z, Li J, Chen J, Lei Q, Han X. Liu Z, et al. Among authors: liu l. Medicine (Baltimore). 2021 Mar 12;100(10):e24683. doi: 10.1097/MD.0000000000024683. Medicine (Baltimore). 2021. PMID: 33725827 Free PMC article.

10

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma.

Liu Z, Wang L, Liu L, Lu T, Jiao D, Sun Y, Han X. Liu Z, et al. Among authors: liu l. Front Oncol. 2021 Mar 2;11:619242. doi: 10.3389/fonc.2021.619242. eCollection 2021. Front Oncol. 2021. PMID: 33738257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,527 results

Search Page

Filters